Pak Fah Yeow International Limited (SEHK: 239)
Health Care · Pharmaceuticals · HK
HK$2.48
+1.43% today · +3.1% 1Y
Pak Fah Yeow International Limited (SEHK: 239) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $98.38M.
Over the last twelve months the share price has gained 3.1%, trading between 2.24 and 2.55.
Tweenvest scores Pak Fah Yeow International Limited across four factors: quality 76/100, value 56/100, growth 32/100, dividend 49/100. Its strongest factor is quality.
239 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $98.38M
- Revenue (TTM)
- $28.15M
- P/E
- —
- EPS
- —
- Dividend yield
- 7.68%
- Beta (5Y)
- 0.40
- 52-week high
- HK$2.55
- 52-week low
- HK$2.24
- Avg volume (3M)
- —
- Shares outstanding
- 311.64M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,248.49 | +0.13% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $272.78 | -0.10% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $155.08 | +2.93% |
| Roche Holding AGSWX: ROP | $368.80B | CHF373.80 | +0.92% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £124.76 | +3.02% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $28.39 | +1.48% |
Figures last refreshed Aug 18, 2026.